Stockreport

Progenity Announces Closing of $40 Million Underwritten Public Offering

Biora Therapeutics, Inc.  (PROG) 
PDF SAN DIEGO, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (“Progenity”) (Nasdaq: PROG), an innovative biotechnology company, today announced the closing of its prev [Read more]